Latest Asx Compliance News

Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

Bentley Capital Limited has addressed a sharp 70% rise in its share price and a spike in trading volume, attributing the movement to ongoing legal proceedings rather than undisclosed information.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Mont Royal Resources Limited will have its trading suspension lifted and resume quotation on the ASX from 5 November 2025 following regulatory compliance.

Pacific Nickel Mines Limited has agreed to sell its entire interest in the Kolosori Nickel Project to Green Rock Limited for a nominal $1, while securing a royalty agreement tied to future nickel ore shipments.

ASF Group Limited has responded to ASX inquiries following a dramatic spike in its share price and trading volume, denying any undisclosed material information and reaffirming compliance with listing rules.

LCL Resources Limited faces suspension from ASX trading due to failure to lodge a required periodic report on time, raising questions about the company’s compliance and operational transparency.

Polymetals Resources Ltd has had its trading suspension lifted following an announcement about a serious safety incident at its Endeavor Mine Site, raising questions about operational impacts and regulatory responses.

Pantera Lithium Limited has had its ASX trading suspension lifted following the release of a significant announcement on material tenement agreements, signaling renewed market activity.

OncoSil Medical Limited has addressed ASX concerns over delayed disclosure of PANCOSIL clinical trial results, confirming compliance with continuous disclosure obligations despite procedural oversights.

Freehill Mining Limited has addressed an ASX query over the late filing of a director’s interest notice, attributing the delay to an administrative oversight and reaffirming its compliance protocols.